David M. Knott Jr’s Xenon Pharmaceuticals XENE Stock Holding History

David M. Knott Jr’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,962	Closed	-$491K	–	94
2025 Q4	$491K	Hold	10,962	–	–	0.23%	49
2025 Q3	$440K	Hold	10,962	–	–	0.18%	56
2025 Q2	$343K	Sell	10,962 -4,904	-31%	-$160K	0.16%	52
2025 Q1	$532K	Sell	15,866 -5,000	-24%	-$190K	0.25%	47
2024 Q4	$818K	Hold	20,866	–	–	0.3%	33
2024 Q3	$821K	Hold	20,866	–	–	0.29%	40
2024 Q2	$814K	Sell	20,866 -3,000	-13%	-$120K	0.32%	42
2024 Q1	$1.03M	Hold	23,866	–	–	0.36%	42
2023 Q4	$1.1M	Hold	23,866	–	–	0.42%	31
2023 Q3	$815K	Hold	23,866	–	–	0.31%	42
2023 Q2	$919K	Sell	23,866 -16,134	-40%	-$641K	0.37%	43
2023 Q1	$1.43M	Sell	40,000 -19,500	-33%	-$720K	0.56%	33
2022 Q4	$2.35M	Hold	59,500	–	–	0.89%	24
2022 Q3	$2.15M	Hold	59,500	–	–	0.9%	21
2022 Q2	$1.81M	Sell	59,500 -7,000	-11%	-$212K	0.76%	32
2022 Q1	$2.03M	Sell	66,500 -19,988	-23%	-$598K	0.65%	41
2021 Q4	$2.7M	Buy	+86,488	New	+$2.58M	0.92%	31

Other funds holding XENE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

David M. Knott Jr's XENE Position: Q1 2026 in Review

David M. Knott Jr sold out of Xenon Pharmaceuticals (XENE) in Q1 2026, closing a stake of 10,962 shares — an estimated $491K sold.

David M. Knott Jr first reported a position in XENE in Q4 2021 and held it in 17 quarters. The position peaked at $2.7M in Q4 2021. 290 funds tracked by Wall St. Rank hold XENE as of Q1 2026.

David M. Knott Jr reported no remaining Xenon Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
David M. Knott Jr sold 10,962 Xenon Pharmaceuticals shares in Q1 2026, an estimated $491K.
David M. Knott Jr first reported a position in Xenon Pharmaceuticals in Q4 2021 and held it in 17 quarters.
David M. Knott Jr's Xenon Pharmaceuticals position peaked at $2.7M in Q4 2021.
290 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q1 2026.

Based on David M. Knott Jr's 13F filing for Q1 2026, filed 14 May 2026.